MetLife Investment Advisors »

Indivior Pharmaceuticals shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Indivior Pharmaceuticals (INDV) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Indivior Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Indivior Pharmaceuticals held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Indivior Pharmaceuticals by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.1M 68k 30.48

More positions owned by MetLife Investment Advisors

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc Class A Cap Stk Cl (GOOGL)
Broadcom (AVGO)
Alphabet Inc Class C Cap Stk Cl (GOOG)
Meta Platforms Inc Class A Cl A (META)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Class B Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
State Street Spdr S&p Etf Trust Tr Unit (SPY)
JPMorgan Chase & Co. (JPM)
Vanguard Short-term Bond Index Fun Short Trm (BSV)
Exxon Mobil Corporation (XOM)

View all positions for MetLife Investment Advisors

Top funds holding Indivior Pharmaceuticals

BlackRock
Vanguard Portfolio Management
Oaktree Capital Management
Vanguard Capital Management
State Street Corporation
Two Seas Capital
Millennium Management
Hanna Zanoni
Madison Avenue Partners
Citadel Advisors
Morgan Stanley
Deerfield Management Company
Geode Capital Management
Mangrove Partners
Goldman Sachs Group

View all funds holding Indivior Pharmaceuticals